Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PRDM5 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
KIF26B - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
F2RL3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
RGS11 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TACSTD2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SHMT2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
B3GALNT1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
OR10H1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
NCOR2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
BRD7P3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors
TSKS - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MAML3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
LOC101929479 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TBC1D9B - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
YWHAB - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
DLG1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
OCEL1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TRADD - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MEA1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
LAMP1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on